StrongBox Wealth LLC raised its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 14,709.1% during the third quarter, HoldingsChannel reports. The fund owned 8,145 shares of the biotechnology company’s stock after purchasing an additional 8,090 shares during the quarter. StrongBox Wealth LLC’s holdings in Axon Enterprise were worth $3,441,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Keel Point LLC lifted its position in shares of Axon Enterprise by 4.4% during the first quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after acquiring an additional 25 shares in the last quarter. Bridgewater Advisors Inc. grew its position in shares of Axon Enterprise by 4.4% in the second quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after purchasing an additional 26 shares in the last quarter. Pinnacle Wealth Planning Services Inc. grew its position in shares of Axon Enterprise by 7.8% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock valued at $153,000 after purchasing an additional 26 shares in the last quarter. Roman Butler Fullerton & Co. grew its position in shares of Axon Enterprise by 2.4% in the first quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after purchasing an additional 30 shares in the last quarter. Finally, 44 Wealth Management LLC raised its stake in shares of Axon Enterprise by 6.0% during the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 30 shares during the period. Institutional investors own 79.08% of the company’s stock.
Key Headlines Impacting Axon Enterprise
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
- Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
- Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
- Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
- Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
- Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a report on Monday. Piper Sandler decreased their price target on Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 20th. Finally, Argus increased their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $688.38.
Get Our Latest Analysis on Axon Enterprise
Axon Enterprise Stock Down 9.8%
AXON opened at $382.56 on Friday. The company has a fifty day moving average price of $447.49 and a 200-day moving average price of $476.73. The firm has a market capitalization of $31.08 billion, a P/E ratio of 158.74, a price-to-earnings-growth ratio of 8.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $665.07.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. During the same period in the previous year, the company posted $1.17 EPS. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. Equities research analysts expect that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Axon Enterprise news, CEO Patrick Smith sold 10,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares in the company, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,397 shares of company stock valued at $21,234,034 over the last 90 days. 4.20% of the stock is owned by insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
